SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1luf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EE2_B_CHDB1250_0 (ALCOHOL DEHYDROGENASE)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	3 / 3	MET A 712 LEU A 715 SER A 716	None	0.68A	1ee2A-1lufA: 0.0	1ee2A-1lufA: 20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GMK_D_DVAD8_0 (GRAMICIDIN A)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	3 / 3	TRP A 767 VAL A 784 TRP A 785	None	1.12A	1gmkC-1lufA: undetectable 1gmkD-1lufA: undetectable	1gmkC-1lufA: 4.56 1gmkD-1lufA: 4.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1IEP_A_STIA201_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 6	LYS A 608 VAL A 638 MET A 657 ARG A 723	None	0.95A	1iepA-1lufA: 35.4	1iepA-1lufA: 37.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JLF_A_NVPA999_1 (HIV-1 RT A-CHAIN HIV-1 RT B-CHAIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 8	LEU A 666 VAL A 732 CYH A 730 GLY A 660	None	1.00A	1jlfA-1lufA: 0.0 1jlfB-1lufA: undetectable	1jlfA-1lufA: 18.25 1jlfB-1lufA: 19.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1OPJ_B_STIB4_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 588 ALA A 606 VAL A 638 GLY A 660 ALA A 741 ASP A 742	None	0.74A	1opjB-1lufA: 34.1	1opjB-1lufA: 37.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EUF_B_LQQB401_1 (CELL DIVISION PROTEIN KINASE 6)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	ILE A 580 VAL A 588 LYS A 608 VAL A 638 PHE A 654 ASP A 661 ASN A 729 LEU A 731 ALA A 741	None	0.87A	2eufB-1lufA: 23.8	2eufB-1lufA: 27.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EUF_B_LQQB401_1 (CELL DIVISION PROTEIN KINASE 6)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	ILE A 580 VAL A 638 PHE A 654 ASP A 661 ASN A 729 LEU A 731 ALA A 741 ASP A 742	None	0.85A	2eufB-1lufA: 23.8	2eufB-1lufA: 27.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2GQG_B_1N1B502_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 LYS A 608 VAL A 638 GLY A 660 LEU A 731 ALA A 741	None	0.60A	2gqgB-1lufA: 31.9	2gqgB-1lufA: 37.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_A_STIA600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 588 ALA A 606 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.71A	2hyyA-1lufA: 35.5	2hyyA-1lufA: 37.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_B_STIB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 588 ALA A 606 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.68A	2hyyB-1lufA: 35.9	2hyyB-1lufA: 37.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HYY_C_STIC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 VAL A 638 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.76A	2hyyC-1lufA: 30.2	2hyyC-1lufA: 37.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2KOT_A_ANWA99_0 (PROTEIN S100-A13)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 7	MET A 604 VAL A 607 PHE A 589 ARG A 578	None	1.21A	2kotA-1lufA: 0.0	2kotA-1lufA: 15.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	VAL A 588 ALA A 606 LYS A 608 TYR A 656 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.70A	2oiqA-1lufA: 28.0	2oiqA-1lufA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OIQ_A_STIA1001_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	VAL A 588 LYS A 608 MET A 629 TYR A 656 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.98A	2oiqA-1lufA: 28.0	2oiqA-1lufA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2PL0_A_STIA200_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	VAL A 588 ALA A 606 LYS A 608 MET A 629 VAL A 638 TYR A 656 LEU A 731 ALA A 741 ASP A 742	None	1.19A	2pl0A-1lufA: 32.3	2pl0A-1lufA: 34.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTH FACTOR RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 TYR A 656 MET A 657 GLY A 660 ALA A 741 ASP A 742	None	0.80A	2wgjA-1lufA: 34.9	2wgjA-1lufA: 33.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2XP2_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 ALA A 606 MET A 657 GLY A 660 LEU A 731 ASP A 742	None	0.68A	2xp2A-1lufA: 32.7	2xp2A-1lufA: 35.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2Y6O_A_1N1A1892_1 (EPHRIN TYPE-A RECEPTOR 4)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ILE A 580 ALA A 606 LYS A 608 MET A 629 TYR A 656 GLY A 660 LEU A 731	None	1.15A	2y6oA-1lufA: 34.1	2y6oA-1lufA: 35.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_A_B49A1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ILE A 580 VAL A 588 ALA A 606 PHE A 654 MET A 657 GLY A 660 LEU A 731	None	0.84A	2y7jA-1lufA: 24.3	2y7jA-1lufA: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_B_B49B1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 10	ILE A 580 VAL A 588 ALA A 606 PHE A 654 MET A 657 GLY A 660 LEU A 731	None	0.92A	2y7jB-1lufA: 24.6	2y7jB-1lufA: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_C_B49C1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 10	ILE A 580 VAL A 588 ALA A 606 PHE A 654 MET A 657 GLY A 660 LEU A 731	None	0.91A	2y7jC-1lufA: 24.2	2y7jC-1lufA: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y7J_D_B49D1294_1 (PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS/LIVER ISOFORM)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 10	ILE A 580 VAL A 588 ALA A 606 PHE A 654 MET A 657 GLY A 660 LEU A 731	None	0.94A	2y7jD-1lufA: 24.3	2y7jD-1lufA: 24.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2YFX_A_VGHA9000_1 (TYROSINE-PROTEIN KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 8	ALA A 606 MET A 657 GLY A 660 LEU A 731	None	0.30A	2yfxA-1lufA: 26.7	2yfxA-1lufA: 35.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ZVA_A_1N1A513_1 (TYROSINE-PROTEIN KINASE LYN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ALA A 606 MET A 629 VAL A 638 MET A 657 GLY A 660 LEU A 731 ALA A 741	None	0.74A	2zvaA-1lufA: 32.5	2zvaA-1lufA: 32.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_A_NILA600_2 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	ALA A 606 GLY A 660 PHE A 720 HIS A 722 LEU A 731 ALA A 741	None	0.60A	3cs9A-1lufA: 35.4	3cs9A-1lufA: 37.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 PHE A 720 HIS A 722 ALA A 741 ASP A 742	None	0.59A	3cs9C-1lufA: 27.9	3cs9C-1lufA: 37.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CS9_D_NILD600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 GLY A 660 PHE A 720 HIS A 722 ALA A 741	None	0.49A	3cs9D-1lufA: 34.1	3cs9D-1lufA: 37.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G0F_A_B49A9001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 11	VAL A 588 ALA A 606 TYR A 656 GLY A 660 ASP A 661 LEU A 731	None	0.57A	3g0fA-1lufA: 35.1	3g0fA-1lufA: 36.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GN8_A_DEXA247_2 (GLUCOCORTICOID RECEPTOR 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	3 / 3	MET A 629 MET A 650 PHE A 743	None	0.95A	3gn8A-1lufA: 0.0	3gn8A-1lufA: 23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GP0_A_NILA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 7	LYS A 608 LEU A 652 MET A 657 ILE A 740	None	0.94A	3gp0A-1lufA: 23.1	3gp0A-1lufA: 23.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GVU_A_STIA1001_1 (TYROSINE-PROTEIN KINASE ABL2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 588 ALA A 606 VAL A 638 LEU A 731 ALA A 741 ASP A 742	None	0.74A	3gvuA-1lufA: 34.3	3gvuA-1lufA: 38.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3IK3_A_0LIA1_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 HIS A 722 LEU A 731 ALA A 741 ASP A 742	None	0.67A	3ik3A-1lufA: 34.5	3ik3A-1lufA: 36.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_A_STIA2_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 588 ALA A 606 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.73A	3k5vA-1lufA: 34.2	3k5vA-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3K5V_B_STIB2_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 588 ALA A 606 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.71A	3k5vB-1lufA: 34.1	3k5vB-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_A_B49A1_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 11	ALA A 606 VAL A 638 PHE A 654 MET A 657 GLY A 660 LEU A 731	None	0.72A	3miyA-1lufA: 32.5	3miyA-1lufA: 32.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MIY_B_B49B2_1 (TYROSINE-PROTEIN KINASE ITK/TSK)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 9	ALA A 606 PHE A 654 MET A 657 GLY A 660 LEU A 731	None	0.68A	3miyB-1lufA: 32.5	3miyB-1lufA: 32.85
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MS9_A_STIA1_2 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 6	LYS A 608 VAL A 638 MET A 657 ARG A 723	None	0.73A	3ms9A-1lufA: 34.7	3ms9A-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_A_STIA1_2 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 6	LYS A 608 VAL A 638 MET A 657 ARG A 723	None	0.77A	3mssA-1lufA: 35.1	3mssA-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_B_STIB1_2 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 7	LYS A 608 VAL A 638 MET A 657 ARG A 723	None	0.95A	3mssB-1lufA: 35.0	3mssB-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_C_STIC1_2 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 6	LYS A 608 VAL A 638 MET A 657 ARG A 723	None	0.81A	3mssC-1lufA: 35.0	3mssC-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	ALA A 606 MET A 629 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	1.10A	3mssD-1lufA: 35.0	3mssD-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MSS_D_STID1_2 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 6	VAL A 588 LYS A 608 VAL A 638 MET A 657	None	0.75A	3mssD-1lufA: 35.0	3mssD-1lufA: 37.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OCT_A_1N1A663_1 (TYROSINE-PROTEIN KINASE BTK)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	VAL A 588 ALA A 606 LYS A 608 MET A 629 VAL A 638 TYR A 656 GLY A 660 LEU A 731	None	1.04A	3octA-1lufA: 31.6	3octA-1lufA: 30.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_A_STIA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 VAL A 638 TYR A 656 GLY A 660 LEU A 731 ALA A 741	None	0.52A	3oezA-1lufA: 27.8	3oezA-1lufA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OEZ_B_STIB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	VAL A 588 ALA A 606 LYS A 608 MET A 629 TYR A 656 LEU A 731 ALA A 741 ASP A 742	None	1.19A	3oezB-1lufA: 27.6	3oezB-1lufA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OXZ_A_0LIA1_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	ALA A 606 VAL A 638 GLY A 660 HIS A 722 ALA A 741 ASP A 742	None	0.69A	3oxzA-1lufA: 33.7	3oxzA-1lufA: 36.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QLG_A_1N1A601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	VAL A 588 ALA A 606 LYS A 608 MET A 629 VAL A 638 TYR A 656 GLY A 660 LEU A 731 ALA A 741	None	0.95A	3qlgA-1lufA: 27.2	3qlgA-1lufA: 32.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 PHE A 654 TYR A 656 LEU A 715 HIS A 722 ALA A 741	None	0.76A	3rgfA-1lufA: 21.4	3rgfA-1lufA: 25.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TI1_A_B49A299_1 (CYCLIN-DEPENDENT KINASE 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	ILE A 580 ALA A 606 VAL A 638 PHE A 654 ASP A 661 LEU A 731	None	0.66A	3ti1A-1lufA: 22.9	3ti1A-1lufA: 24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U8Q_A_NPUA7231_1 (LACTOTRANSFERRIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 5	THR A 603 GLY A 595 PRO A 598 TYR A 599	None	1.19A	3u8qA-1lufA: undetectable	3u8qA-1lufA: 22.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3UG2_A_IREA1_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 LYS A 608 LEU A 652 MET A 657 GLY A 660 LEU A 731	None	0.84A	3ug2A-1lufA: 24.8	3ug2A-1lufA: 31.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V5W_A_8PRA701_1 (G-PROTEIN COUPLED RECEPTOR KINASE 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	ILE A 580 GLY A 583 GLY A 586 VAL A 588 ALA A 606 LYS A 608	None	0.71A	3v5wA-1lufA: 7.9	3v5wA-1lufA: 19.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WZE_A_BAXA1201_2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 8	VAL A 638 LEU A 731 ILE A 740 ASP A 742	None	0.59A	3wzeA-1lufA: 29.3	3wzeA-1lufA: 34.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZBF_A_VGHA3000_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 MET A 657 GLY A 660 ASP A 661 LEU A 731	None	0.30A	3zbfA-1lufA: 33.4	3zbfA-1lufA: 35.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ALA A 606 LYS A 608 LEU A 715 HIS A 722 LEU A 731 ALA A 741 ASP A 742	None	0.74A	3zosA-1lufA: 28.5	3zosA-1lufA: 39.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 9	MET A 629 ILE A 637 TYR A 656 MET A 657 ILE A 740	None	0.69A	3zosA-1lufA: 28.5	3zosA-1lufA: 39.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ALA A 606 LYS A 608 LEU A 715 HIS A 722 LEU A 731 ALA A 741 ASP A 742	None	0.73A	3zosB-1lufA: 35.7	3zosB-1lufA: 39.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 9	MET A 629 ILE A 637 TYR A 656 MET A 657 ILE A 740	None	0.71A	3zosB-1lufA: 35.7	3zosB-1lufA: 39.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 ALA A 606 MET A 657 GLY A 660 LEU A 731 ALA A 741	None	0.64A	4anqA-1lufA: 32.6	4anqA-1lufA: 36.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANQ_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 ALA A 606 MET A 657 LEU A 731 ALA A 741 ASP A 742	None	0.68A	4anqA-1lufA: 32.6	4anqA-1lufA: 36.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANS_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 ALA A 606 MET A 657 GLY A 660 LEU A 731 ALA A 741	None	0.65A	4ansA-1lufA: 32.6	4ansA-1lufA: 36.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ANS_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 ALA A 606 MET A 657 LEU A 731 ALA A 741 ASP A 742	None	0.69A	4ansA-1lufA: 32.6	4ansA-1lufA: 36.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 MET A 629 TYR A 656 LEU A 731 ALA A 741 ASP A 742	None	0.89A	4bkjA-1lufA: 28.9	4bkjA-1lufA: 39.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4BKJ_B_STIB1000_2 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 5	LYS A 608 TYR A 656 MET A 657 ARG A 723	None	0.89A	4bkjB-1lufA: 36.1	4bkjB-1lufA: 39.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 5	VAL A 588 ILE A 637 TYR A 656 MET A 657 ILE A 740	None	0.45A	4c8bA-1lufA: 27.8	4c8bA-1lufA: 27.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ALA A 606 LYS A 608 ILE A 637 HIS A 722 LEU A 731 ALA A 741 ASP A 742	None	0.68A	4c8bB-1lufA: 27.3	4c8bB-1lufA: 27.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	3 / 3	TYR A 656 MET A 657 ILE A 637	None	0.55A	4c8bB-1lufA: 27.3	4c8bB-1lufA: 27.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_2 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	3 / 3	TYR A 656 MET A 657 ILE A 740	None	0.19A	4c8bB-1lufA: 27.3	4c8bB-1lufA: 27.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKI_A_ADNA2022_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 11	GLY A 581 VAL A 588 ALA A 606 TYR A 656 GLY A 660 LEU A 731	None	0.74A	4ckiA-1lufA: 26.8	4ckiA-1lufA: 37.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CSV_A_STIA1265_1 (SRC-ABL TYROSINE KINASE ANCESTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	VAL A 588 ALA A 606 MET A 629 VAL A 638 TYR A 656 LEU A 731 ALA A 741 ASP A 742	None	1.01A	4csvA-1lufA: 33.8	4csvA-1lufA: 38.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_A_8PRA601_1 (RHODOPSIN KINASE)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 7	ALA A 606 MET A 657 ASP A 661 LEU A 731	None	0.81A	4l9iA-1lufA: 8.2	4l9iA-1lufA: 22.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXX_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 VAL A 638 TYR A 656 MET A 657 GLY A 660 LEU A 731	None	0.53A	4mxxB-1lufA: 32.1	4mxxB-1lufA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXY_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	VAL A 588 ALA A 606 LYS A 608 VAL A 638 TYR A 656 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.86A	4mxyB-1lufA: 25.7	4mxyB-1lufA: 33.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4MXZ_B_DB8B601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	VAL A 588 ALA A 606 LYS A 608 VAL A 638 TYR A 656 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.86A	4mxzB-1lufA: 25.7	4mxzB-1lufA: 33.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O2B_D_LOCD503_1 (TUBULIN ALPHA-1B CHAIN TUBULIN BETA-2B CHAIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	3 / 3	SER A 782 ALA A 786 VAL A 789	None	0.62A	4o2bC-1lufA: undetectable	4o2bC-1lufA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_E_ADNE401_1 (CYCLIN-DEPENDENT KINASE 9)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 7	ALA A 606 ASP A 661 ASN A 729 LEU A 731 ASP A 742	None	0.89A	4ogrE-1lufA: 22.6	4ogrE-1lufA: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	ILE A 580 GLY A 744 ALA A 606 ASP A 661 ASN A 729 LEU A 731	None	0.88A	4ogrI-1lufA: 22.8	4ogrI-1lufA: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	ILE A 580 GLY A 744 ASP A 661 ASN A 729 LEU A 731 ASP A 742	None	0.99A	4ogrI-1lufA: 22.8	4ogrI-1lufA: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OGR_I_ADNI401_1 (CYCLIN-DEPENDENT KINASE 9)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	ILE A 580 VAL A 588 ALA A 606 ASP A 661 ASN A 729 LEU A 731	None	0.91A	4ogrI-1lufA: 22.8	4ogrI-1lufA: 23.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P65_A_IPHA101_0 (INSULIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 10	LEU A 855 CYH A 698 LEU A 702 ALA A 705 LEU A 791	None	1.00A	4p65A-1lufA: undetectable 4p65B-1lufA: undetectable 4p65F-1lufA: undetectable 4p65H-1lufA: undetectable	4p65A-1lufA: 4.47 4p65B-1lufA: 6.34 4p65F-1lufA: 6.34 4p65H-1lufA: 6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P65_C_IPHC101_0 (INSULIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 11	LEU A 855 CYH A 698 LEU A 702 ALA A 705 LEU A 791	None	0.99A	4p65C-1lufA: undetectable 4p65D-1lufA: undetectable 4p65J-1lufA: undetectable 4p65L-1lufA: undetectable	4p65C-1lufA: 4.47 4p65D-1lufA: 6.34 4p65J-1lufA: 6.34 4p65L-1lufA: 6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P65_G_IPHG101_0 (INSULIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 11	LEU A 791 LEU A 855 CYH A 698 LEU A 702 ALA A 705	None	1.04A	4p65B-1lufA: undetectable 4p65D-1lufA: undetectable 4p65G-1lufA: undetectable 4p65H-1lufA: undetectable	4p65B-1lufA: 6.34 4p65D-1lufA: 6.34 4p65G-1lufA: 4.47 4p65H-1lufA: 6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P65_I_IPHI101_0 (INSULIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	LEU A 791 LEU A 855 CYH A 698 LEU A 702 ALA A 705	None	0.96A	4p65B-1lufA: undetectable 4p65D-1lufA: undetectable 4p65I-1lufA: undetectable 4p65J-1lufA: undetectable	4p65B-1lufA: 6.34 4p65D-1lufA: 6.34 4p65I-1lufA: 4.47 4p65J-1lufA: 6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P65_K_IPHK101_0 (INSULIN)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	LEU A 791 LEU A 855 CYH A 698 LEU A 702 ALA A 705	None	1.04A	4p65F-1lufA: undetectable 4p65H-1lufA: undetectable 4p65K-1lufA: undetectable 4p65L-1lufA: undetectable	4p65F-1lufA: 6.34 4p65H-1lufA: 6.34 4p65K-1lufA: 4.47 4p65L-1lufA: 6.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QMN_A_DB8A401_1 (SERINE/THREONINE-PRO TEIN KINASE 24)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	ALA A 606 LYS A 608 TYR A 656 LEU A 731 ALA A 741 ASP A 742	None	0.74A	4qmnA-1lufA: 26.5	4qmnA-1lufA: 24.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QRC_A_0LIA802_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 8	VAL A 588 LYS A 608 HIS A 722 LEU A 731	None	0.72A	4qrcA-1lufA: 34.2	4qrcA-1lufA: 40.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWP_A_AXIA601_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	VAL A 588 ALA A 606 LYS A 608 MET A 657 GLY A 660 ASN A 729 LEU A 731 ALA A 741 ASP A 742	None	0.64A	4twpA-1lufA: 32.3	4twpA-1lufA: 35.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TWP_B_AXIB601_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	VAL A 588 ALA A 606 LYS A 608 MET A 657 GLY A 660 ASN A 729 LEU A 731 ALA A 741 ASP A 742	None	0.65A	4twpB-1lufA: 32.6	4twpB-1lufA: 35.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 HIS A 722 LEU A 731 ALA A 741 ASP A 742	None	0.66A	4tyjA-1lufA: 34.4	4tyjA-1lufA: 41.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4TYJ_A_0LIA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 6	VAL A 588 LYS A 608 ILE A 637 ARG A 723 ILE A 740	None	0.99A	4tyjA-1lufA: 34.4	4tyjA-1lufA: 41.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_1 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 10	VAL A 588 ILE A 637 VAL A 638 TYR A 656 ARG A 723 ILE A 740	None	0.82A	4u0iA-1lufA: 36.3	4u0iA-1lufA: 36.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	ALA A 606 LYS A 608 GLY A 660 HIS A 722 LEU A 731 ASP A 742	None	0.60A	4u0iA-1lufA: 36.3	4u0iA-1lufA: 36.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_A_RXTA601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	10 / 11	GLY A 583 VAL A 588 ALA A 606 TYR A 656 MET A 657 GLY A 660 ASN A 729 LEU A 731 ALA A 741 ASP A 742	None	0.92A	4u5jA-1lufA: 32.9	4u5jA-1lufA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4U5J_B_RXTB601_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 9	VAL A 588 ALA A 606 TYR A 656 MET A 657 GLY A 660 LEU A 731 ASP A 742	None	0.62A	4u5jB-1lufA: 27.1	4u5jB-1lufA: 32.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4UXQ_A_0LIA1752_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 LEU A 715 HIS A 722 LEU A 731 ALA A 741	None	0.53A	4uxqA-1lufA: 34.8	4uxqA-1lufA: 41.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 LEU A 715 HIS A 722 ALA A 741 ASP A 742	None	0.69A	4v01A-1lufA: 34.0	4v01A-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_A_0LIA1776_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 LYS A 608 TYR A 656 ARG A 723 LEU A 731 ILE A 740	None	1.03A	4v01A-1lufA: 34.0	4v01A-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 LEU A 715 HIS A 722 ALA A 741 ASP A 742	None	0.62A	4v01B-1lufA: 34.3	4v01B-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V01_B_0LIB1770_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 LYS A 608 TYR A 656 ARG A 723 LEU A 731 ILE A 740	None	0.77A	4v01B-1lufA: 34.3	4v01B-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 588 ALA A 606 LEU A 715 HIS A 722 ALA A 741 ASP A 742	None	0.80A	4v04A-1lufA: 33.6	4v04A-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_A_0LIA1772_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 8	LYS A 608 TYR A 656 ARG A 723 LEU A 731 ILE A 740	None	1.31A	4v04A-1lufA: 33.6	4v04A-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_1 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 10	VAL A 588 LYS A 608 TYR A 656 ARG A 723 LEU A 731 ILE A 740	None	1.17A	4v04B-1lufA: 34.4	4v04B-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4V04_B_0LIB1771_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	ALA A 606 LEU A 715 HIS A 722 ALA A 741 ASP A 742	None	0.64A	4v04B-1lufA: 34.4	4v04B-1lufA: 38.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_A_AXIA9000_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 11	ALA A 606 MET A 657 GLY A 660 ASN A 729 LEU A 731 ALA A 741	None	0.48A	4wa9A-1lufA: 28.4	4wa9A-1lufA: 36.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4WA9_B_AXIB9000_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	VAL A 588 ALA A 606 LYS A 608 MET A 657 GLY A 660 ASN A 729 LEU A 731 ALA A 741	None	0.58A	4wa9B-1lufA: 32.4	4wa9B-1lufA: 36.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_A_1N1A601_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	ALA A 606 LYS A 608 MET A 629 VAL A 638 TYR A 656 MET A 657 GLY A 660 LEU A 731 ALA A 741	None	0.99A	4xliA-1lufA: 32.9	4xliA-1lufA: 37.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4XLI_B_1N1B600_1 (NON-SPECIFIC PROTEIN-TYROSINE KINASE)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ALA A 606 LYS A 608 VAL A 638 TYR A 656 GLY A 660 LEU A 731 ALA A 741	None	0.58A	4xliB-1lufA: 32.7	4xliB-1lufA: 37.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4ZAU_A_YY3A1101_1 (EPIDERMAL GROWTH FACTOR RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 8	GLY A 581 VAL A 588 ALA A 606 MET A 657 GLY A 660	None	0.52A	4zauA-1lufA: 31.0	4zauA-1lufA: 31.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	LEU A 628 ALA A 630 LEU A 652 LEU A 640 LEU A 564	None	1.19A	4zn7A-1lufA: undetectable	4zn7A-1lufA: 21.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAA_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 9	VAL A 588 ALA A 606 MET A 657 GLY A 660 LEU A 731 ASP A 742	None	0.67A	5aaaA-1lufA: 33.1	5aaaA-1lufA: 35.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AAB_A_VGHA9000_1 (ALK TYROSINE KINASE RECEPTOR)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 10	VAL A 588 ALA A 606 LYS A 608 MET A 657 GLY A 660 LEU A 731 ASP A 742	None	0.86A	5aabA-1lufA: 32.7	5aabA-1lufA: 35.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AJQ_B_DB8B800_1 (SERINE/THREONINE-PRO TEIN KINASE 10)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 10	ALA A 606 GLY A 660 LEU A 731 ALA A 741 ASP A 742	None	0.61A	5ajqB-1lufA: 23.5	5ajqB-1lufA: 23.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HI2_A_BAXA801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 8	VAL A 588 ILE A 637 ILE A 740 ASP A 742	None	0.47A	5hi2A-1lufA: 20.1	5hi2A-1lufA: 29.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IWU_A_ERYA404_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 6	GLY A 798 ASP A 724 ILE A 765 ARG A 766	None	1.04A	5iwuA-1lufA: 6.8	5iwuA-1lufA: 22.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	ILE A 580 GLY A 581 VAL A 588 ALA A 606 VAL A 638 PHE A 654 ASP A 661 LEU A 731	None	0.71A	5l2iA-1lufA: 7.0	5l2iA-1lufA: 26.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2I_A_LQQA900_1 (CYCLIN-DEPENDENT KINASE 6)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	ILE A 580 VAL A 588 ALA A 606 VAL A 638 PHE A 654 ASP A 661 LEU A 731 ALA A 741	None	0.66A	5l2iA-1lufA: 7.0	5l2iA-1lufA: 26.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	9 / 12	ILE A 580 GLY A 581 VAL A 588 ALA A 606 VAL A 638 PHE A 654 ASP A 661 LEU A 731 ALA A 741	None	0.87A	5l2tA-1lufA: 7.1	5l2tA-1lufA: 26.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L2T_A_6ZZA900_1 (CYCLIN-DEPENDENT KINASE 6)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	VAL A 638 PHE A 654 ASP A 661 LEU A 731 ALA A 741 ASP A 742	None	0.83A	5l2tA-1lufA: 7.1	5l2tA-1lufA: 26.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	6 / 12	ALA A 606 VAL A 638 PHE A 720 HIS A 722 LEU A 731 ALA A 741	None	0.71A	5mo4A-1lufA: 12.0	5mo4A-1lufA: 29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MO4_A_NILA601_2 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	VAL A 638 PHE A 720 HIS A 722 ALA A 741 ASP A 742	None	0.65A	5mo4A-1lufA: 12.0	5mo4A-1lufA: 29.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VC3_A_DB8A601_2 (WEE1-LIKE PROTEIN KINASE)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 4	VAL A 588 LYS A 608 VAL A 638 ASN A 729	None	0.89A	5vc3A-1lufA: 23.4	5vc3A-1lufA: 22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XV7_A_EMHA705_1 (SERINE-ARGININE (SR) PROTEIN KINASE 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 12	GLY A 581 VAL A 588 ALA A 606 PHE A 654 ALA A 741	None	0.63A	5xv7A-1lufA: 21.1	5xv7A-1lufA: 11.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	3 / 3	LYS A 608 LEU A 731 ASP A 742	None	0.91A	5zv2A-1lufA: 33.0	5zv2A-1lufA: 20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BSD_A_1N1A901_0 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	8 / 12	VAL A 588 ALA A 606 LYS A 608 TYR A 656 MET A 657 GLY A 660 LEU A 731 ASP A 742	None	1.16A	6bsdA-1lufA: 28.2	6bsdA-1lufA: 17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CZM_A_HISA402_0 (ATP PHOSPHORIBOSYLTRANSF ERASE CATALYTIC SUBUNIT)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	5 / 10	GLY A 595 LEU A 596 VAL A 607 ALA A 591 LEU A 653	None	1.16A	6czmA-1lufA: undetectable 6czmC-1lufA: undetectable	6czmA-1lufA: 21.43 6czmC-1lufA: 21.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6HD4_A_STIA604_0 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ALA A 606 LYS A 608 MET A 629 VAL A 638 LEU A 731 ALA A 741 ASP A 742	None	1.16A	6hd4A-1lufA: 34.0	6hd4A-1lufA: 31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6HD4_A_STIA604_0 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 LYS A 608 VAL A 638 LEU A 731 ALA A 741 ASP A 742	None	0.86A	6hd4A-1lufA: 34.0	6hd4A-1lufA: 31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	ALA A 606 LYS A 608 MET A 629 VAL A 638 LEU A 731 ALA A 741 ASP A 742	None	1.18A	6hd4B-1lufA: 34.0	6hd4B-1lufA: 31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 LYS A 608 VAL A 638 LEU A 731 ALA A 741 ASP A 742	None	0.89A	6hd4B-1lufA: 34.0	6hd4B-1lufA: 31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6HD6_A_STIA603_0 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	7 / 12	VAL A 588 ALA A 606 LYS A 608 VAL A 638 LEU A 731 ALA A 741 ASP A 742	None	0.86A	6hd6A-1lufA: 34.1	6hd6A-1lufA: 31.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6HD6_B_STIB601_1 (TYROSINE-PROTEIN KINASE ABL1)	1luf	MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK (Rattus norvegicus)	4 / 7	MET A 657 GLY A 660 ARG A 723 ALA A 741	None	0.44A	6hd6B-1lufA: 33.9	6hd6B-1lufA: 31.03

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1EE2_B_CHDB1250_0","ALCOHOL DEHYDROGENASE","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",3,"MET A 712;LEU A 715;SER A 716","None","0.68A","1ee2A-1lufA:0.0","1ee2A-1lufA:20.90"],["1GMK_D_DVAD8_0","GRAMICIDIN A","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",3,"TRP A 767;VAL A 784;TRP A 785","None","1.12A","1gmkC-1lufA:undetectable;1gmkD-1lufA:undetectable","1gmkC-1lufA:4.56;1gmkD-1lufA:4.56"],["1IEP_A_STIA201_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LYS A 608;VAL A 638;MET A 657;ARG A 723","None","0.95A","1iepA-1lufA:35.4","1iepA-1lufA:37.22"],["1JLF_A_NVPA999_1","HIV-1 RT A-CHAIN;HIV-1 RT B-CHAIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LEU A 666;VAL A 732;CYH A 730;GLY A 660","None","1.00A","1jlfA-1lufA:0.0;1jlfB-1lufA:undetectable","1jlfA-1lufA:18.25;1jlfB-1lufA:19.43"],["1OPJ_B_STIB4_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;VAL A 638;GLY A 660;ALA A 741;ASP A 742","None","0.74A","1opjB-1lufA:34.1","1opjB-1lufA:37.22"],["2EUF_B_LQQB401_1","CELL DIVISION PROTEIN KINASE 6","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"ILE A 580;VAL A 588;LYS A 608;VAL A 638;PHE A 654;ASP A 661;ASN A 729;LEU A 731;ALA A 741","None","0.87A","2eufB-1lufA:23.8","2eufB-1lufA:27.81"],["2EUF_B_LQQB401_1","CELL DIVISION PROTEIN KINASE 6","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"ILE A 580;VAL A 638;PHE A 654;ASP A 661;ASN A 729;LEU A 731;ALA A 741;ASP A 742","None","0.85A","2eufB-1lufA:23.8","2eufB-1lufA:27.81"],["2GQG_B_1N1B502_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;LYS A 608;VAL A 638;GLY A 660;LEU A 731;ALA A 741","None","0.60A","2gqgB-1lufA:31.9","2gqgB-1lufA:37.76"],["2HYY_A_STIA600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.71A","2hyyA-1lufA:35.5","2hyyA-1lufA:37.65"],["2HYY_B_STIB600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.68A","2hyyB-1lufA:35.9","2hyyB-1lufA:37.65"],["2HYY_C_STIC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;VAL A 638;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.76A","2hyyC-1lufA:30.2","2hyyC-1lufA:37.65"],["2KOT_A_ANWA99_0","PROTEIN S100-A13","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"MET A 604;VAL A 607;PHE A 589;ARG A 578","None","1.21A","2kotA-1lufA:0.0","2kotA-1lufA:15.97"],["2OIQ_A_STIA1001_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"VAL A 588;ALA A 606;LYS A 608;TYR A 656;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.70A","2oiqA-1lufA:28.0","2oiqA-1lufA:32.57"],["2OIQ_A_STIA1001_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"VAL A 588;LYS A 608;MET A 629;TYR A 656;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.98A","2oiqA-1lufA:28.0","2oiqA-1lufA:32.57"],["2PL0_A_STIA200_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"VAL A 588;ALA A 606;LYS A 608;MET A 629;VAL A 638;TYR A 656;LEU A 731;ALA A 741;ASP A 742","None","1.19A","2pl0A-1lufA:32.3","2pl0A-1lufA:34.40"],["2WGJ_A_VGHA2346_1","HEPATOCYTE GROWTH FACTOR RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;TYR A 656;MET A 657;GLY A 660;ALA A 741;ASP A 742","None","0.80A","2wgjA-1lufA:34.9","2wgjA-1lufA:33.33"],["2XP2_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;MET A 657;GLY A 660;LEU A 731;ASP A 742","None","0.68A","2xp2A-1lufA:32.7","2xp2A-1lufA:35.46"],["2Y6O_A_1N1A1892_1","EPHRIN TYPE-A RECEPTOR 4","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ILE A 580;ALA A 606;LYS A 608;MET A 629;TYR A 656;GLY A 660;LEU A 731","None","1.15A","2y6oA-1lufA:34.1","2y6oA-1lufA:35.14"],["2Y7J_A_B49A1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ILE A 580;VAL A 588;ALA A 606;PHE A 654;MET A 657;GLY A 660;LEU A 731","None","0.84A","2y7jA-1lufA:24.3","2y7jA-1lufA:24.10"],["2Y7J_B_B49B1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ILE A 580;VAL A 588;ALA A 606;PHE A 654;MET A 657;GLY A 660;LEU A 731","None","0.92A","2y7jB-1lufA:24.6","2y7jB-1lufA:24.10"],["2Y7J_C_B49C1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ILE A 580;VAL A 588;ALA A 606;PHE A 654;MET A 657;GLY A 660;LEU A 731","None","0.91A","2y7jC-1lufA:24.2","2y7jC-1lufA:24.10"],["2Y7J_D_B49D1294_1","PHOSPHORYLASE B KINASE GAMMA CATALYTIC CHAIN, TESTIS\/LIVER ISOFORM","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ILE A 580;VAL A 588;ALA A 606;PHE A 654;MET A 657;GLY A 660;LEU A 731","None","0.94A","2y7jD-1lufA:24.3","2y7jD-1lufA:24.10"],["2YFX_A_VGHA9000_1","TYROSINE-PROTEIN KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"ALA A 606;MET A 657;GLY A 660;LEU A 731","None","0.30A","2yfxA-1lufA:26.7","2yfxA-1lufA:35.46"],["2ZVA_A_1N1A513_1","TYROSINE-PROTEIN KINASE LYN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ALA A 606;MET A 629;VAL A 638;MET A 657;GLY A 660;LEU A 731;ALA A 741","None","0.74A","2zvaA-1lufA:32.5","2zvaA-1lufA:32.27"],["3CS9_A_NILA600_2","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;GLY A 660;PHE A 720;HIS A 722;LEU A 731;ALA A 741","None","0.60A","3cs9A-1lufA:35.4","3cs9A-1lufA:37.76"],["3CS9_C_NILC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;PHE A 720;HIS A 722;ALA A 741;ASP A 742","None","0.59A","3cs9C-1lufA:27.9","3cs9C-1lufA:37.76"],["3CS9_D_NILD600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;GLY A 660;PHE A 720;HIS A 722;ALA A 741","None","0.49A","3cs9D-1lufA:34.1","3cs9D-1lufA:37.76"],["3G0F_A_B49A9001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;TYR A 656;GLY A 660;ASP A 661;LEU A 731","None","0.57A","3g0fA-1lufA:35.1","3g0fA-1lufA:36.75"],["3GN8_A_DEXA247_2","GLUCOCORTICOID RECEPTOR 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",3,"MET A 629;MET A 650;PHE A 743","None","0.95A","3gn8A-1lufA:0.0","3gn8A-1lufA:23.05"],["3GP0_A_NILA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 11","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LYS A 608;LEU A 652;MET A 657;ILE A 740","None","0.94A","3gp0A-1lufA:23.1","3gp0A-1lufA:23.08"],["3GVU_A_STIA1001_1","TYROSINE-PROTEIN KINASE ABL2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;VAL A 638;LEU A 731;ALA A 741;ASP A 742","None","0.74A","3gvuA-1lufA:34.3","3gvuA-1lufA:38.82"],["3IK3_A_0LIA1_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;HIS A 722;LEU A 731;ALA A 741;ASP A 742","None","0.67A","3ik3A-1lufA:34.5","3ik3A-1lufA:36.36"],["3K5V_A_STIA2_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.73A","3k5vA-1lufA:34.2","3k5vA-1lufA:37.22"],["3K5V_B_STIB2_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.71A","3k5vB-1lufA:34.1","3k5vB-1lufA:37.22"],["3MIY_A_B49A1_1","TYROSINE-PROTEIN KINASE ITK\/TSK","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;VAL A 638;PHE A 654;MET A 657;GLY A 660;LEU A 731","None","0.72A","3miyA-1lufA:32.5","3miyA-1lufA:32.85"],["3MIY_B_B49B2_1","TYROSINE-PROTEIN KINASE ITK\/TSK","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;PHE A 654;MET A 657;GLY A 660;LEU A 731","None","0.68A","3miyB-1lufA:32.5","3miyB-1lufA:32.85"],["3MS9_A_STIA1_2","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LYS A 608;VAL A 638;MET A 657;ARG A 723","None","0.73A","3ms9A-1lufA:34.7","3ms9A-1lufA:37.22"],["3MSS_A_STIA1_2","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LYS A 608;VAL A 638;MET A 657;ARG A 723","None","0.77A","3mssA-1lufA:35.1","3mssA-1lufA:37.22"],["3MSS_B_STIB1_2","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LYS A 608;VAL A 638;MET A 657;ARG A 723","None","0.95A","3mssB-1lufA:35.0","3mssB-1lufA:37.22"],["3MSS_C_STIC1_2","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LYS A 608;VAL A 638;MET A 657;ARG A 723","None","0.81A","3mssC-1lufA:35.0","3mssC-1lufA:37.22"],["3MSS_D_STID1_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;MET A 629;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","1.10A","3mssD-1lufA:35.0","3mssD-1lufA:37.22"],["3MSS_D_STID1_2","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"VAL A 588;LYS A 608;VAL A 638;MET A 657","None","0.75A","3mssD-1lufA:35.0","3mssD-1lufA:37.22"],["3OCT_A_1N1A663_1","TYROSINE-PROTEIN KINASE BTK","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"VAL A 588;ALA A 606;LYS A 608;MET A 629;VAL A 638;TYR A 656;GLY A 660;LEU A 731","None","1.04A","3octA-1lufA:31.6","3octA-1lufA:30.72"],["3OEZ_A_STIA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;VAL A 638;TYR A 656;GLY A 660;LEU A 731;ALA A 741","None","0.52A","3oezA-1lufA:27.8","3oezA-1lufA:32.57"],["3OEZ_B_STIB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"VAL A 588;ALA A 606;LYS A 608;MET A 629;TYR A 656;LEU A 731;ALA A 741;ASP A 742","None","1.19A","3oezB-1lufA:27.6","3oezB-1lufA:32.57"],["3OXZ_A_0LIA1_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;VAL A 638;GLY A 660;HIS A 722;ALA A 741;ASP A 742","None","0.69A","3oxzA-1lufA:33.7","3oxzA-1lufA:36.73"],["3QLG_A_1N1A601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"VAL A 588;ALA A 606;LYS A 608;MET A 629;VAL A 638;TYR A 656;GLY A 660;LEU A 731;ALA A 741","None","0.95A","3qlgA-1lufA:27.2","3qlgA-1lufA:32.57"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;PHE A 654;TYR A 656;LEU A 715;HIS A 722;ALA A 741","None","0.76A","3rgfA-1lufA:21.4","3rgfA-1lufA:25.94"],["3TI1_A_B49A299_1","CYCLIN-DEPENDENT KINASE 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ILE A 580;ALA A 606;VAL A 638;PHE A 654;ASP A 661;LEU A 731","None","0.66A","3ti1A-1lufA:22.9","3ti1A-1lufA:24.59"],["3U8Q_A_NPUA7231_1","LACTOTRANSFERRIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"THR A 603;GLY A 595;PRO A 598;TYR A 599","None","1.19A","3u8qA-1lufA:undetectable","3u8qA-1lufA:22.82"],["3UG2_A_IREA1_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;LYS A 608;LEU A 652;MET A 657;GLY A 660;LEU A 731","None","0.84A","3ug2A-1lufA:24.8","3ug2A-1lufA:31.13"],["3V5W_A_8PRA701_1","G-PROTEIN COUPLED RECEPTOR KINASE 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ILE A 580;GLY A 583;GLY A 586;VAL A 588;ALA A 606;LYS A 608","None","0.71A","3v5wA-1lufA:7.9","3v5wA-1lufA:19.94"],["3WZE_A_BAXA1201_2","VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"VAL A 638;LEU A 731;ILE A 740;ASP A 742","None","0.59A","3wzeA-1lufA:29.3","3wzeA-1lufA:34.28"],["3ZBF_A_VGHA3000_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;MET A 657;GLY A 660;ASP A 661;LEU A 731","None","0.30A","3zbfA-1lufA:33.4","3zbfA-1lufA:35.77"],["3ZOS_A_0LIA1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ALA A 606;LYS A 608;LEU A 715;HIS A 722;LEU A 731;ALA A 741;ASP A 742","None","0.74A","3zosA-1lufA:28.5","3zosA-1lufA:39.20"],["3ZOS_A_0LIA1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"MET A 629;ILE A 637;TYR A 656;MET A 657;ILE A 740","None","0.69A","3zosA-1lufA:28.5","3zosA-1lufA:39.20"],["3ZOS_B_0LIB1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ALA A 606;LYS A 608;LEU A 715;HIS A 722;LEU A 731;ALA A 741;ASP A 742","None","0.73A","3zosB-1lufA:35.7","3zosB-1lufA:39.20"],["3ZOS_B_0LIB1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"MET A 629;ILE A 637;TYR A 656;MET A 657;ILE A 740","None","0.71A","3zosB-1lufA:35.7","3zosB-1lufA:39.20"],["4ANQ_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;MET A 657;GLY A 660;LEU A 731;ALA A 741","None","0.64A","4anqA-1lufA:32.6","4anqA-1lufA:36.01"],["4ANQ_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;MET A 657;LEU A 731;ALA A 741;ASP A 742","None","0.68A","4anqA-1lufA:32.6","4anqA-1lufA:36.01"],["4ANS_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;MET A 657;GLY A 660;LEU A 731;ALA A 741","None","0.65A","4ansA-1lufA:32.6","4ansA-1lufA:36.01"],["4ANS_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;MET A 657;LEU A 731;ALA A 741;ASP A 742","None","0.69A","4ansA-1lufA:32.6","4ansA-1lufA:36.01"],["4BKJ_A_STIA1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;MET A 629;TYR A 656;LEU A 731;ALA A 741;ASP A 742","None","0.89A","4bkjA-1lufA:28.9","4bkjA-1lufA:39.20"],["4BKJ_B_STIB1000_2","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"LYS A 608;TYR A 656;MET A 657;ARG A 723","None","0.89A","4bkjB-1lufA:36.1","4bkjB-1lufA:39.20"],["4C8B_A_0LIA1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"VAL A 588;ILE A 637;TYR A 656;MET A 657;ILE A 740","None","0.45A","4c8bA-1lufA:27.8","4c8bA-1lufA:27.42"],["4C8B_B_0LIB1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ALA A 606;LYS A 608;ILE A 637;HIS A 722;LEU A 731;ALA A 741;ASP A 742","None","0.68A","4c8bB-1lufA:27.3","4c8bB-1lufA:27.42"],["4C8B_B_0LIB1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",3,"TYR A 656;MET A 657;ILE A 637","None","0.55A","4c8bB-1lufA:27.3","4c8bB-1lufA:27.42"],["4C8B_B_0LIB1000_2","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",3,"TYR A 656;MET A 657;ILE A 740","None","0.19A","4c8bB-1lufA:27.3","4c8bB-1lufA:27.42"],["4CKI_A_ADNA2022_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"GLY A 581;VAL A 588;ALA A 606;TYR A 656;GLY A 660;LEU A 731","None","0.74A","4ckiA-1lufA:26.8","4ckiA-1lufA:37.43"],["4CSV_A_STIA1265_1","SRC-ABL TYROSINE KINASE ANCESTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"VAL A 588;ALA A 606;MET A 629;VAL A 638;TYR A 656;LEU A 731;ALA A 741;ASP A 742","None","1.01A","4csvA-1lufA:33.8","4csvA-1lufA:38.51"],["4L9I_A_8PRA601_1","RHODOPSIN KINASE","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"ALA A 606;MET A 657;ASP A 661;LEU A 731","None","0.81A","4l9iA-1lufA:8.2","4l9iA-1lufA:22.24"],["4MXX_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;VAL A 638;TYR A 656;MET A 657;GLY A 660;LEU A 731","None","0.53A","4mxxB-1lufA:32.1","4mxxB-1lufA:32.57"],["4MXY_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"VAL A 588;ALA A 606;LYS A 608;VAL A 638;TYR A 656;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.86A","4mxyB-1lufA:25.7","4mxyB-1lufA:33.14"],["4MXZ_B_DB8B601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"VAL A 588;ALA A 606;LYS A 608;VAL A 638;TYR A 656;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.86A","4mxzB-1lufA:25.7","4mxzB-1lufA:33.14"],["4O2B_D_LOCD503_1","TUBULIN ALPHA-1B CHAIN;TUBULIN BETA-2B CHAIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",3,"SER A 782;ALA A 786;VAL A 789","None","0.62A","4o2bC-1lufA:undetectable","4o2bC-1lufA:20.00"],["4OGR_E_ADNE401_1","CYCLIN-DEPENDENT KINASE 9","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;ASP A 661;ASN A 729;LEU A 731;ASP A 742","None","0.89A","4ogrE-1lufA:22.6","4ogrE-1lufA:23.02"],["4OGR_I_ADNI401_1","CYCLIN-DEPENDENT KINASE 9","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ILE A 580;GLY A 744;ALA A 606;ASP A 661;ASN A 729;LEU A 731","None","0.88A","4ogrI-1lufA:22.8","4ogrI-1lufA:23.02"],["4OGR_I_ADNI401_1","CYCLIN-DEPENDENT KINASE 9","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ILE A 580;GLY A 744;ASP A 661;ASN A 729;LEU A 731;ASP A 742","None","0.99A","4ogrI-1lufA:22.8","4ogrI-1lufA:23.02"],["4OGR_I_ADNI401_1","CYCLIN-DEPENDENT KINASE 9","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ILE A 580;VAL A 588;ALA A 606;ASP A 661;ASN A 729;LEU A 731","None","0.91A","4ogrI-1lufA:22.8","4ogrI-1lufA:23.02"],["4P65_A_IPHA101_0","INSULIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"LEU A 855;CYH A 698;LEU A 702;ALA A 705;LEU A 791","None","1.00A","4p65A-1lufA:undetectable;4p65B-1lufA:undetectable;4p65F-1lufA:undetectable;4p65H-1lufA:undetectable","4p65A-1lufA:4.47;4p65B-1lufA:6.34;4p65F-1lufA:6.34;4p65H-1lufA:6.34"],["4P65_C_IPHC101_0","INSULIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"LEU A 855;CYH A 698;LEU A 702;ALA A 705;LEU A 791","None","0.99A","4p65C-1lufA:undetectable;4p65D-1lufA:undetectable;4p65J-1lufA:undetectable;4p65L-1lufA:undetectable","4p65C-1lufA:4.47;4p65D-1lufA:6.34;4p65J-1lufA:6.34;4p65L-1lufA:6.34"],["4P65_G_IPHG101_0","INSULIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"LEU A 791;LEU A 855;CYH A 698;LEU A 702;ALA A 705","None","1.04A","4p65B-1lufA:undetectable;4p65D-1lufA:undetectable;4p65G-1lufA:undetectable;4p65H-1lufA:undetectable","4p65B-1lufA:6.34;4p65D-1lufA:6.34;4p65G-1lufA:4.47;4p65H-1lufA:6.34"],["4P65_I_IPHI101_0","INSULIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"LEU A 791;LEU A 855;CYH A 698;LEU A 702;ALA A 705","None","0.96A","4p65B-1lufA:undetectable;4p65D-1lufA:undetectable;4p65I-1lufA:undetectable;4p65J-1lufA:undetectable","4p65B-1lufA:6.34;4p65D-1lufA:6.34;4p65I-1lufA:4.47;4p65J-1lufA:6.34"],["4P65_K_IPHK101_0","INSULIN","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"LEU A 791;LEU A 855;CYH A 698;LEU A 702;ALA A 705","None","1.04A","4p65F-1lufA:undetectable;4p65H-1lufA:undetectable;4p65K-1lufA:undetectable;4p65L-1lufA:undetectable","4p65F-1lufA:6.34;4p65H-1lufA:6.34;4p65K-1lufA:4.47;4p65L-1lufA:6.34"],["4QMN_A_DB8A401_1","SERINE\/THREONINE-PROTEIN KINASE 24","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;LYS A 608;TYR A 656;LEU A 731;ALA A 741;ASP A 742","None","0.74A","4qmnA-1lufA:26.5","4qmnA-1lufA:24.31"],["4QRC_A_0LIA802_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"VAL A 588;LYS A 608;HIS A 722;LEU A 731","None","0.72A","4qrcA-1lufA:34.2","4qrcA-1lufA:40.86"],["4TWP_A_AXIA601_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"VAL A 588;ALA A 606;LYS A 608;MET A 657;GLY A 660;ASN A 729;LEU A 731;ALA A 741;ASP A 742","None","0.64A","4twpA-1lufA:32.3","4twpA-1lufA:35.67"],["4TWP_B_AXIB601_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"VAL A 588;ALA A 606;LYS A 608;MET A 657;GLY A 660;ASN A 729;LEU A 731;ALA A 741;ASP A 742","None","0.65A","4twpB-1lufA:32.6","4twpB-1lufA:35.67"],["4TYJ_A_0LIA801_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;HIS A 722;LEU A 731;ALA A 741;ASP A 742","None","0.66A","4tyjA-1lufA:34.4","4tyjA-1lufA:41.69"],["4TYJ_A_0LIA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"VAL A 588;LYS A 608;ILE A 637;ARG A 723;ILE A 740","None","0.99A","4tyjA-1lufA:34.4","4tyjA-1lufA:41.69"],["4U0I_A_0LIA1001_1","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ILE A 637;VAL A 638;TYR A 656;ARG A 723;ILE A 740","None","0.82A","4u0iA-1lufA:36.3","4u0iA-1lufA:36.75"],["4U0I_A_0LIA1001_2","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;LYS A 608;GLY A 660;HIS A 722;LEU A 731;ASP A 742","None","0.60A","4u0iA-1lufA:36.3","4u0iA-1lufA:36.75"],["4U5J_A_RXTA601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",10,"GLY A 583;VAL A 588;ALA A 606;TYR A 656;MET A 657;GLY A 660;ASN A 729;LEU A 731;ALA A 741;ASP A 742","None","0.92A","4u5jA-1lufA:32.9","4u5jA-1lufA:32.57"],["4U5J_B_RXTB601_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;TYR A 656;MET A 657;GLY A 660;LEU A 731;ASP A 742","None","0.62A","4u5jB-1lufA:27.1","4u5jB-1lufA:32.57"],["4UXQ_A_0LIA1752_1","FIBROBLAST GROWTH FACTOR RECEPTOR 4","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;LEU A 715;HIS A 722;LEU A 731;ALA A 741","None","0.53A","4uxqA-1lufA:34.8","4uxqA-1lufA:41.57"],["4V01_A_0LIA1776_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;LEU A 715;HIS A 722;ALA A 741;ASP A 742","None","0.69A","4v01A-1lufA:34.0","4v01A-1lufA:38.15"],["4V01_A_0LIA1776_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;LYS A 608;TYR A 656;ARG A 723;LEU A 731;ILE A 740","None","1.03A","4v01A-1lufA:34.0","4v01A-1lufA:38.15"],["4V01_B_0LIB1770_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;LEU A 715;HIS A 722;ALA A 741;ASP A 742","None","0.62A","4v01B-1lufA:34.3","4v01B-1lufA:38.15"],["4V01_B_0LIB1770_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;LYS A 608;TYR A 656;ARG A 723;LEU A 731;ILE A 740","None","0.77A","4v01B-1lufA:34.3","4v01B-1lufA:38.15"],["4V04_A_0LIA1772_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;LEU A 715;HIS A 722;ALA A 741;ASP A 742","None","0.80A","4v04A-1lufA:33.6","4v04A-1lufA:38.15"],["4V04_A_0LIA1772_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"LYS A 608;TYR A 656;ARG A 723;LEU A 731;ILE A 740","None","1.31A","4v04A-1lufA:33.6","4v04A-1lufA:38.15"],["4V04_B_0LIB1771_1","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;LYS A 608;TYR A 656;ARG A 723;LEU A 731;ILE A 740","None","1.17A","4v04B-1lufA:34.4","4v04B-1lufA:38.15"],["4V04_B_0LIB1771_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1 (FMS-RELATED TYROSINE KINASE 2, PFEIFFER SYNDROME), ISOFORM CRA_B","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;LEU A 715;HIS A 722;ALA A 741;ASP A 742","None","0.64A","4v04B-1lufA:34.4","4v04B-1lufA:38.15"],["4WA9_A_AXIA9000_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;MET A 657;GLY A 660;ASN A 729;LEU A 731;ALA A 741","None","0.48A","4wa9A-1lufA:28.4","4wa9A-1lufA:36.68"],["4WA9_B_AXIB9000_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"VAL A 588;ALA A 606;LYS A 608;MET A 657;GLY A 660;ASN A 729;LEU A 731;ALA A 741","None","0.58A","4wa9B-1lufA:32.4","4wa9B-1lufA:36.68"],["4XLI_A_1N1A601_1","NON-SPECIFIC PROTEIN-TYROSINE KINASE","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"ALA A 606;LYS A 608;MET A 629;VAL A 638;TYR A 656;MET A 657;GLY A 660;LEU A 731;ALA A 741","None","0.99A","4xliA-1lufA:32.9","4xliA-1lufA:37.39"],["4XLI_B_1N1B600_1","NON-SPECIFIC PROTEIN-TYROSINE KINASE","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ALA A 606;LYS A 608;VAL A 638;TYR A 656;GLY A 660;LEU A 731;ALA A 741","None","0.58A","4xliB-1lufA:32.7","4xliB-1lufA:37.39"],["4ZAU_A_YY3A1101_1","EPIDERMAL GROWTH FACTOR RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"GLY A 581;VAL A 588;ALA A 606;MET A 657;GLY A 660","None","0.52A","4zauA-1lufA:31.0","4zauA-1lufA:31.91"],["4ZN7_A_DESA601_1","ESTROGEN RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"LEU A 628;ALA A 630;LEU A 652;LEU A 640;LEU A 564","None","1.19A","4zn7A-1lufA:undetectable","4zn7A-1lufA:21.33"],["5AAA_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 588;ALA A 606;MET A 657;GLY A 660;LEU A 731;ASP A 742","None","0.67A","5aaaA-1lufA:33.1","5aaaA-1lufA:35.46"],["5AAB_A_VGHA9000_1","ALK TYROSINE KINASE RECEPTOR","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;LYS A 608;MET A 657;GLY A 660;LEU A 731;ASP A 742","None","0.86A","5aabA-1lufA:32.7","5aabA-1lufA:35.46"],["5AJQ_B_DB8B800_1","SERINE\/THREONINE-PROTEIN KINASE 10","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"ALA A 606;GLY A 660;LEU A 731;ALA A 741;ASP A 742","None","0.61A","5ajqB-1lufA:23.5","5ajqB-1lufA:23.90"],["5HI2_A_BAXA801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"VAL A 588;ILE A 637;ILE A 740;ASP A 742","None","0.47A","5hi2A-1lufA:20.1","5hi2A-1lufA:29.34"],["5IWU_A_ERYA404_1","MACROLIDE 2'-PHOSPHOTRANSFERASE II","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"GLY A 798;ASP A 724;ILE A 765;ARG A 766","None","1.04A","5iwuA-1lufA:6.8","5iwuA-1lufA:22.93"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"ILE A 580;GLY A 581;VAL A 588;ALA A 606;VAL A 638;PHE A 654;ASP A 661;LEU A 731","None","0.71A","5l2iA-1lufA:7.0","5l2iA-1lufA:26.98"],["5L2I_A_LQQA900_1","CYCLIN-DEPENDENT KINASE 6","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"ILE A 580;VAL A 588;ALA A 606;VAL A 638;PHE A 654;ASP A 661;LEU A 731;ALA A 741","None","0.66A","5l2iA-1lufA:7.0","5l2iA-1lufA:26.98"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",9,"ILE A 580;GLY A 581;VAL A 588;ALA A 606;VAL A 638;PHE A 654;ASP A 661;LEU A 731;ALA A 741","None","0.87A","5l2tA-1lufA:7.1","5l2tA-1lufA:26.98"],["5L2T_A_6ZZA900_1","CYCLIN-DEPENDENT KINASE 6","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"VAL A 638;PHE A 654;ASP A 661;LEU A 731;ALA A 741;ASP A 742","None","0.83A","5l2tA-1lufA:7.1","5l2tA-1lufA:26.98"],["5MO4_A_NILA601_2","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",6,"ALA A 606;VAL A 638;PHE A 720;HIS A 722;LEU A 731;ALA A 741","None","0.71A","5mo4A-1lufA:12.0","5mo4A-1lufA:29.81"],["5MO4_A_NILA601_2","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"VAL A 638;PHE A 720;HIS A 722;ALA A 741;ASP A 742","None","0.65A","5mo4A-1lufA:12.0","5mo4A-1lufA:29.81"],["5VC3_A_DB8A601_2","WEE1-LIKE PROTEIN KINASE","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"VAL A 588;LYS A 608;VAL A 638;ASN A 729","None","0.89A","5vc3A-1lufA:23.4","5vc3A-1lufA:22.60"],["5XV7_A_EMHA705_1","SERINE-ARGININE (SR) PROTEIN KINASE 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"GLY A 581;VAL A 588;ALA A 606;PHE A 654;ALA A 741","None","0.63A","5xv7A-1lufA:21.1","5xv7A-1lufA:11.99"],["5ZV2_A_LEVA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",3,"LYS A 608;LEU A 731;ASP A 742","None","0.91A","5zv2A-1lufA:33.0","5zv2A-1lufA:20.17"],["6BSD_A_1N1A901_0","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",8,"VAL A 588;ALA A 606;LYS A 608;TYR A 656;MET A 657;GLY A 660;LEU A 731;ASP A 742","None","1.16A","6bsdA-1lufA:28.2","6bsdA-1lufA:17.27"],["6CZM_A_HISA402_0","ATP PHOSPHORIBOSYLTRANSFERASE CATALYTIC SUBUNIT","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",5,"GLY A 595;LEU A 596;VAL A 607;ALA A 591;LEU A 653","None","1.16A","6czmA-1lufA:undetectable;6czmC-1lufA:undetectable","6czmA-1lufA:21.43;6czmC-1lufA:21.43"],["6HD4_A_STIA604_0","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ALA A 606;LYS A 608;MET A 629;VAL A 638;LEU A 731;ALA A 741;ASP A 742","None","1.16A","6hd4A-1lufA:34.0","6hd4A-1lufA:31.03"],["6HD4_A_STIA604_0","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;LYS A 608;VAL A 638;LEU A 731;ALA A 741;ASP A 742","None","0.86A","6hd4A-1lufA:34.0","6hd4A-1lufA:31.03"],["6HD4_B_STIB602_0","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"ALA A 606;LYS A 608;MET A 629;VAL A 638;LEU A 731;ALA A 741;ASP A 742","None","1.18A","6hd4B-1lufA:34.0","6hd4B-1lufA:31.03"],["6HD4_B_STIB602_0","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;LYS A 608;VAL A 638;LEU A 731;ALA A 741;ASP A 742","None","0.89A","6hd4B-1lufA:34.0","6hd4B-1lufA:31.03"],["6HD6_A_STIA603_0","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",7,"VAL A 588;ALA A 606;LYS A 608;VAL A 638;LEU A 731;ALA A 741;ASP A 742","None","0.86A","6hd6A-1lufA:34.1","6hd6A-1lufA:31.03"],["6HD6_B_STIB601_1","TYROSINE-PROTEIN KINASE ABL1","1luf","MUSCLE-SPECIFIC TYROSINE KINASE RECEPTOR MUSK","Rattus norvegicus",4,"MET A 657;GLY A 660;ARG A 723;ALA A 741","None","0.44A","6hd6B-1lufA:33.9","6hd6B-1lufA:31.03"]]